Goldman Sachs Lifts Merck Stock Target to $160

Analysts at The Goldman Sachs Group have increased their price target for Merck & Co., Inc. (NYSE:MRK) stock from $140.00 to $160.00, indicating a potential upside of 5.39% from the company's previous close.

The firm currently has a 'buy' rating on the stock and is one of fifteen research analysts who have rated Merck & Co., Inc. with a 'buy' rating, while eight have given it a 'hold' rating. The average price target for MRK is $144.10, according to MarketBeat.com.

Merck & Co., Inc.'s stock has been on the rise, trading up 1.9% at $151.82 per share with an average volume of 10,815,531 shares traded daily. The company's market capitalization is $374.57 billion, and its price-to-earnings ratio is 121.46.